MeiraGTx Holdings plc

MGTX Nasdaq SEC CIK 1735438
Follow MeiraGTx Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $4.8M +1074.1% vs same quarter last year
Net income −$51.2M −1.4% vs same quarter last year
EPS, diluted −$0.53 +14.5% vs same quarter last year
Operating cash flow −$24.5M −101% vs same quarter last year
Revenue by quarter
$21.4M
$1.9M
$3.7M
$410K
$75.4M
$293K
$321.4M
$4.8M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income10 fiscal years
  • Revenue
  • Net income
−$200M−$100M$0$100MFY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$81.4M−$114.2M
FY24$33.3M−$147.8M
FY23$14M−$84M
FY22$15.9M−$129.6M
FY21$37.7M−$79.6M
FY20$15.6M−$58M
FY19$13.3M−$54.7M
FY18-−$82.9M
FY17-−$31M
FY16--
MarginsShare of revenue
  • Operating margin
  • Net margin
−1000%−750%−500%−250%0%FY17FY19FY21FY23FY25
Show the numbers
YearOperating marginNet margin
FY25−130.2%−140.3%
FY24−493.4%−444.1%
FY23−977.8%−599.5%
FY22−730.9%−814.2%
FY21−193%−211%
FY20−401.9%−372.6%
FY19−438.4%−411.9%
FY18--
FY17--
FY16--
Free cash flowOperating cash flow minus capital expenditure
−$150M−$100M−$50M$0$50MFY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$50.2M
FY24−$109.5M
FY23−$125.5M
FY22−$118.1M
FY21−$56.9M
FY20−$84.9M
FY19$11.1M
FY18−$70.1M
FY17−$28.6M
FY16-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • MeiraGTx
  • Healthcare median
−1000%−750%−500%−250%0%FY17FY19FY21FY23FY25
Show the numbers
YearMeiraGTxHealthcare median
FY25−140.3%−30.6%
FY24−444.1%−47%
FY23−599.5%−58%
FY22−814.2%−80.4%
FY21−211%−71.8%
FY20−372.6%−62.2%
FY19−411.9%−46.2%
FY18-−49.6%
FY17-−45.9%
FY16-−36%